FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 330:153-158 January 20, 1994 Number 3 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The efficacy of surgery for patients with non-small-cell lung cancer is limited, although recent studies suggest that preoperative chemotherapy may improve survival. We conducted a randomized trial to examine the possible benefit of preoperative chemotherapy and surgery for the treatment of patients with non-small-cell lung cancer.

Methods We studied 60 patients (59 men and 1 woman) with stage IIIA non-small-cell lung cancer. The patients were randomly assigned to receive either surgery alone or three courses of chemotherapy (6 mg of mitomycin per square meter of body-surface area, 3 g of ifosfamide per square meter, and 50 mg of cisplatin per square meter) given intravenously at three-week intervals and followed by surgery. All patients received mediastinal radiation after surgery. The resected tumors were evaluated by means of K-ras oncogene analysis and flow cytometry.

Results The median period of survival was 26 months in the patients treated with chemotherapy plus surgery, as compared with 8 months in the patients treated with surgery alone (P<0.001); the median period of disease-free survival was 20 months in the former group, as compared with 5 months in the latter (P<0.001). The rate of recurrence was 56 percent in the group treated with chemotherapy plus surgery and 74 percent in the group treated with surgery alone. The prevalence of mutated K-ras oncogenes was 15 percent among the patients receiving preoperative chemotherapy and 42 percent among those treated with surgery alone (P = 0.05). Most of the patients treated with chemotherapy plus surgery had tumors that consisted of diploid cells, whereas the patients treated with surgery alone had tumors with aneuploid cells.

Conclusions Preoperative chemotherapy increases the median survival in patients with non-small-cell lung cancer.

Source Information

From the Departments of Medical Oncology (R.R., S.L., Z.S., A.A.), Thoracic Surgery (J.M., M.C.), Pneumology (J.R., J.M.-P.), Radiology (A.O.), and Pathology (J.L.M., A.A.), University of Barcelona, Hospital de Badalona Germans Trias i Pujol, Barcelona; the Departments of Medical Oncology (J.G.-C.) and Thoracic Surgery (J.P.), Hospital La Fe, Valencia; and the Departments of Medical Oncology (C.C.) and Thoracic Surgery (A.C.), Hospital General, Valencia -- all in Spain. Presented in part at the 28th annual meeting of the American Society of Clinical Oncology, San Diego, Calif., May 17-19, 1992.

Address reprint requests to Dr. Rosell at the Medical Oncology Department, University Hospital Germans Trias i Pujol, Box 72, 08916 Badalona (Barcelona), Spain.

Full Text of this Article

Related Letters:

Chemotherapy plus Surgery versus Surgery Alone in Non-Small-Cell Lung Cancer
Cocquyt V., De Neve W., Van Belle S. J.-P., Chanarin N., Mills N. E., Fishman C. L., Jacobson D. R., McLachlan S.-A., Stockler M., Rosell R.
Extract | Full Text  
N Engl J Med 1994; 330:1756-1757, Jun 16, 1994. Correspondence

This article has been cited by other articles:

• Moretti, L., Yu, D. S., Chen, H., Carbone, D. P., Johnson, D. H., Keedy, V. L., Putnam, J. B. Jr., Sandler, A. B., Shyr, Y., Lu, B. (2009). Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy. The Oncologist 14: 1106-1115 [Abstract] [Full Text]  
• Ratto, G. B., Costa, R., Maineri, P., Alloisio, A., Bruzzi, P., Dozin, B. (2009). Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?. J. Thorac. Cardiovasc. Surg. 138: 849-858 [Abstract] [Full Text]  
• Kassis, E. S., Vaporciyan, A. A., Swisher, S. G., Correa, A. M., Bekele, B. N., Erasmus, J. J., Hofstetter, W. L., Komaki, R., Mehran, R. J., Moran, C. A., Pisters, K. M., Rice, D. C., Walsh, G. L., Roth, J. A. (2009). Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J. Thorac. Cardiovasc. Surg. 138: 412-418 [Abstract] [Full Text]  
• Steger, V., Walles, T., Kosan, B., Walker, T., Kyriss, T., Veit, S., Dippon, J., Friedel, G. (2009). Trimodal Therapy for Histologically Proven N2/3 Non-Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival.. Ann. Thorac. Surg. 87: 1676-1683 [Abstract] [Full Text]  
• Lin, C.-S., Wang, L.-S., Tsai, C.-M., Wei, Y.-H. (2008). Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. ICVTS 7: 954-958 [Abstract] [Full Text]  
• Misthos, P., Sepsas, E., Kokotsakis, J., Skottis, I., Lioulias, A. (2008). The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer. Ann. Thorac. Surg. 86: 1626-1630 [Abstract] [Full Text]  
• Moss, M. (2008). Clinical Year in Review I: Lung Cancer, Pleural Disease, Exercise Testing and Pulmonary Rehabilitation, and Sleep Medicine. Proc Am Thorac Soc 5: 739-744 [Full Text]  
• Gudbjartsson, T., Gyllstedt, E., Pikwer, A., Jonsson, P. (2008). Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy. Ann. Thorac. Surg. 86: 376-382 [Abstract] [Full Text]  
• Mansour, Z., Kochetkova, E. A., Santelmo, N., Ducrocq, X., Quoix, E., Wihlm, J.-M., Massard, G. (2008). Persistent N2 Disease After Induction Therapy Does Not Jeopardize Early and Medium Term Outcomes of Pneumonectomy. Ann. Thorac. Surg. 86: 228-233 [Abstract] [Full Text]  
• Alifano, M., Boudaya, M. S., Salvi, M., Collet, J.-Y., Dinu, C., Camilleri-Broet, S., Regnard, J.-F. (2008). Pneumonectomy After Chemotherapy: Morbidity, Mortality, and Long-Term Outcome. Ann. Thorac. Surg. 85: 1866-1873 [Abstract] [Full Text]  
• Kandioler, D., Stamatis, G., Eberhardt, W., Kappel, S., Zochbauer-Muller, S., Kuhrer, I., Mittlbock, M., Zwrtek, R., Aigner, C., Bichler, C., Tichy, V., Hudec, M., Bachleitner, T., End, A., Muller, M. R., Roth, E., Klepetko, W. (2008). Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.. J. Thorac. Cardiovasc. Surg. 135: 1036-1041 [Abstract] [Full Text]  
• Silvestri, G A, Spiro, S G (2008). Carcinoma of the bronchus 60 years later. Postgrad. Med. J. 84: 182-187 [Full Text]  
• Borri, A., Leo, F., Veronesi, G., Solli, P., Galetta, D., Gasparri, R., Petrella, F., Scanagatta, P., Radice, D., Spaggiari, L. (2007). Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results.. J. Thorac. Cardiovasc. Surg. 134: 1266-1272 [Abstract] [Full Text]  
• Garrido, P., Gonzalez-Larriba, J. L., Insa, A., Provencio, M., Torres, A., Isla, D., Sanchez, J. M., Cardenal, F., Domine, M., Barcelo, J. R., Tarrazona, V., Varela, A., Aguilo, R., Astudillo, J., Muguruza, I., Artal, A., Hernando-Trancho, F., Massuti, B., Sanchez-Ronco, M., Rosell, R. (2007). Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901. JCO 25: 4736-4742 [Abstract] [Full Text]  
• Robinson, L. A., Ruckdeschel, J. C., Wagner, H. Jr, Stevens, C. W. (2007). Treatment of Non-small Cell Lung Cancer-Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132: 243S-265S [Abstract] [Full Text]  
• Uy, K. L., Darling, G., Xu, W., Yi, Q.-L., De Perrot, M., Pierre, A. F., Waddell, T. K., Johnston, M. R., Bezjak, A., Shepherd, F. A., Keshavjee, S. (2007). Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 134: 188-193 [Abstract] [Full Text]  
• Yokomise, H., Gotoh, M., Okamoto, T., Yamamoto, Y., Ishikawa, S., Nakashima, T., Masuya, D., Liu, D., Huang, C.-l. (2007). Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non small cell lung cancer. J. Thorac. Cardiovasc. Surg. 133: 1179-1185 [Abstract] [Full Text]  
• Venuta, F., Anile, M., Diso, D., Ibrahim, M., De Giacomo, T., Rolla, M., Liparulo, V., Coloni, G. F. (2007). Operative complications and early mortality after induction therapy for lung cancer. Eur. J. Cardiothorac. Surg. 31: 714-717 [Abstract] [Full Text]  
• Mansour, Z., Kochetkova, E. A., Ducrocq, X., Vasilescu, M.-D., Maxant, G., Buggenhout, A., Wihlm, J.-M., Massard, G. (2007). Induction chemotherapy does not increase the operative risk of pneumonectomy!. Eur. J. Cardiothorac. Surg. 31: 181-185 [Abstract] [Full Text]  
• Spaggiari, L., Leo, F., Veronesi, G., Solli, P., Galetta, D., Tatani, B., Petrella, F., Radice, D. (2007). Superior Vena Cava Resection for Lung and Mediastinal Malignancies: A Single-Center Experience With 70 Cases. Ann. Thorac. Surg. 83: 223-230 [Abstract] [Full Text]  
• Marra, A., Eberhardt, W., Pottgen, C., Theegarten, D., Korfee, S., Gauler, T., Stuschke, M., Stamatis, G. (2007). Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour. Eur Respir J 29: 117-126 [Abstract] [Full Text]  
• Cerfolio, R. J., Bryant, A. S., Eloubeidi, M. A. (2006). Routine Mediastinoscopy and Esophageal Ultrasound Fine-Needle Aspiration in Patients With Non-small Cell Lung Cancer Who Are Clinically N2 Negative: A Prospective Study. Chest 130: 1791-1795 [Abstract] [Full Text]  
• Silvestri, G A, Spiro, S G (2006). Carcinoma of the bronchus 60 years later.. Thorax 61: 1023-1028 [Full Text]  
• Leo, F., Solli, P., Veronesi, G., Radice, D., Floridi, A., Gasparri, R., Petrella, F., Borri, A., Galetta, D., Spaggiari, L. (2006). Does chemotherapy increase the risk of respiratory complications after pneumonectomy?. J. Thorac. Cardiovasc. Surg. 132: 519-523 [Abstract] [Full Text]  
• De Leyn, P., Stroobants, S., De Wever, W., Lerut, T., Coosemans, W., Decker, G., Nafteux, P., Van Raemdonck, D., Mortelmans, L., Nackaerts, K., Vansteenkiste, J. (2006). Prospective Comparative Study of Integrated Positron Emission Tomography-Computed Tomography Scan Compared With Remediastinoscopy in the Assessment of Residual Mediastinal Lymph Node Disease After Induction Chemotherapy for Mediastinoscopy-Proven Stage IIIA-N2 Non-Small-Cell Lung Cancer: A Leuven Lung Cancer Group Study. JCO 24: 3333-3339 [Abstract] [Full Text]  
• Petersen, R. P., Pham, D., Toloza, E. M., Burfeind, W. R., Harpole, D. H. Jr, Hanish, S. I., D'Amico, T. A. (2006). Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.. Ann. Thorac. Surg. 82: 214-218 [Abstract] [Full Text]  
• Takeda, S.-i., Maeda, H., Okada, T., Yamaguchi, T., Nakagawa, M., Yokota, S., Sawabata, N., Ohta, M. (2006). Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.. Eur. J. Cardiothorac. Surg. 30: 184-189 [Abstract] [Full Text]  
• Fujita, S., Katakami, N., Takahashi, Y., Hirokawa, K., Ikeda, A., Tabata, C., Mio, T., Mishima, M. (2006). Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer.. Eur. J. Cardiothorac. Surg. 29: 896-901 [Abstract] [Full Text]  
• Brunelli, A., Xiume', F., Al Refai, M., Salati, M., Marasco, R., Sabbatini, A. (2006). Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome. Ann. Thorac. Surg. 81: 1963-1968 [Abstract] [Full Text]  
• Cerfolio, R. J., Bryant, A. S. (2006). Distribution and Likelihood of Lymph Node Metastasis Based on the Lobar Location of Nonsmall-Cell Lung Cancer. Ann. Thorac. Surg. 81: 1969-1973 [Abstract] [Full Text]  
• Meyers, B. F., Haddad, F., Siegel, B. A., Zoole, J. B., Battafarano, R. J., Veeramachaneni, N., Cooper, J. D., Patterson, G. A. (2006). Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J. Thorac. Cardiovasc. Surg. 131: 822-829 [Abstract] [Full Text]  
• Funakoshi, Y., Takeda, S.-i., Sawabata, N., Okumura, Y., Maeda, H. (2005). Long-Term Pulmonary Function after Lobectomy for Primary Lung Cancer. Asian Cardiovasc. Thorac. Ann. 13: 311-315 [Abstract] [Full Text]  
• Martin, L. W., Correa, A. M., Hofstetter, W., Hong, W. K., Komaki, R., Putnam, J. B. Jr, Rice, D. C., Smythe, W. R., Swisher, S. G., Vaporciyan, A. A., Walsh, G. L., Roth, J. A. (2005). The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J. Thorac. Cardiovasc. Surg. 130: 1601-1610 [Abstract] [Full Text]  
• (2005). Additional Information. JAMA 294: E1-E3 [Full Text]  
• Barlesi, F., Doddoli, C., Torre, J.-P., Giudicelli, R., Fuentes, P., Thomas, P., Astoul, P. (2005). Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy. Eur. J. Cardiothorac. Surg. 28: 629-634 [Abstract] [Full Text]  
• Spiro, S. G., Silvestri, G. A. (2005). One Hundred Years of Lung Cancer. Am. J. Respir. Crit. Care Med. 172: 523-529 [Abstract] [Full Text]  
• Perrot, E., Guibert, B., Mulsant, P., Blandin, S., Arnaud, I., Roy, P., Geriniere, L., Souquet, P.-J. (2005). Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection. Ann. Thorac. Surg. 80: 423-427 [Abstract] [Full Text]  
• Casali, C., Stefani, A., Natali, P., Rossi, G., Morandi, U. (2005). Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur. J. Cardiothorac. Surg. 28: 33-38 [Abstract] [Full Text]  
• Cerfolio, R. J., Bryant, A. S., Ohja, B., Bartolucci, A. A. (2005). The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J. Thorac. Cardiovasc. Surg. 130: 151-159 [Abstract] [Full Text]  
• Bogart, J. A., Aronowitz, J. N. (2005). Localized Non-Small Cell Lung Cancer: Adjuvant Radiotherapy in the Era of Effective Systemic Therapy. Clin. Cancer Res. 11: 5004s-5010s [Abstract] [Full Text]  
• DeCamp, M. M. Jr., Ashiku, S., Thurer, R. (2005). The Role of Surgery in N2 Non-Small Cell Lung Cancer. Clin. Cancer Res. 11: 5033s-5037s [Abstract] [Full Text]  
• Thatcher, N., Faivre-Finn, C., Blackhall, F., Anderson, H., Lorigan, P. (2005). Sequential Platinum-Based Chemotherapy-Thoracic Radiotherapy in Early Stage Non-Small Cell Lung Cancer. Clin. Cancer Res. 11: 5051s-5056s [Abstract] [Full Text]  
• Pezzetta, E., Stupp, R., Zouhair, A., Guillou, L., Taffe, P., von Briel, C., Krueger, T., Ris, H.-B. (2005). Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC. Eur. J. Cardiothorac. Surg. 27: 1092-1098 [Abstract] [Full Text]  
• Farray, D., Mirkovic, N., Albain, K. S. (2005). Multimodality Therapy for Stage III Non-Small-Cell Lung Cancer. JCO 23: 3257-3269 [Abstract] [Full Text]  
• Patel, V., Shrager, J. B. (2005). Which Patients with Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection?. The Oncologist 10: 335-344 [Abstract] [Full Text]  
• Pramesh, C.S., Mistry, R. C., Agarwal, J. (2005). Chest wall resection in patients with non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 27: 731-731 [Full Text]  
• Matsuoka, H. (2005). Reply to Pramesh et al.. Eur. J. Cardiothorac. Surg. 27: 732-732 [Full Text]  
• Caddy, G., Conron, M., Wright, G., Desmond, P., Hart, D., Chen, R. Y. (2005). The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur Respir J 25: 410-415 [Abstract] [Full Text]  
• Mamon, H. J., Yeap, B. Y., Janne, P. A., Reblando, J., Shrager, S., Jaklitsch, M. T., Mentzer, S., Lukanich, J. M., Sugarbaker, D. J., Baldini, E. H., Berman, S., Skarin, A., Bueno, R. (2005). High Risk of Brain Metastases in Surgically Staged IIIA Non-Small-Cell Lung Cancer Patients Treated With Surgery, Chemotherapy, and Radiation. JCO 23: 1530-1537 [Abstract] [Full Text]  
• Choi, I. S., Oh, D.-Y., Kwon, J. H., Kim, S.-I., Park, S. R., Bak, J.-Y., Kim, J. H., Kim, D.-W., Kim, Y. T., Kim, T.-Y., You, C.-K., Kim, Y. W., Heo, D. S., Bang, Y.-J., Sung, S. W., Park, C.-I., Kim, N. K. (2005). Paclitaxel/Platinum-based Perioperative Chemotherapy and Surgery in Stage IIIA Non-small Cell Lung Cancer. Jpn J Clin Oncol 35: 6-12 [Abstract] [Full Text]  
• Cerfolio, R. J., Bryant, A. S., Winokur, T. S., Ohja, B., Bartolucci, A. A. (2004). Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer. Ann. Thorac. Surg. 78: 1903-1909 [Abstract] [Full Text]  
• Lorent, N., De Leyn, P., Lievens, Y., Verbeken, E., Nackaerts, K., Dooms, C., Van Raemdonck, D., Anrys, B., Vansteenkiste, J., The Leuven Lung Cancer Group, (2004). Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 15: 1645-1653 [Abstract] [Full Text]  
• Taron, M., Rosell, R., Felip, E., Mendez, P., Souglakos, J., Ronco, M. S., Queralt, C., Majo, J., Sanchez, J. M., Sanchez, J. J., Maestre, J. (2004). BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. Hum Mol Genet 13: 2443-2449 [Abstract] [Full Text]  
• Sedrakyan, A., van Der Meulen, J., O'Byrne, K., Prendiville, J., Hill, J., Treasure, T. (2004). Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. J. Thorac. Cardiovasc. Surg. 128: 414-419 [Abstract] [Full Text]  
• Cerfolio, R. J., Ojha, B., Bryant, A. S., Raghuveer, V., Mountz, J. M., Bartolucci, A. A. (2004). The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer. Ann. Thorac. Surg. 78: 1017-1023 [Abstract] [Full Text]  
• Lynch, T. J., Wright, C. D., Choi, N. C., Aquino, S. L., Mark, E. J. (2004). Case 26-2004 - A 56-Year-Old Woman with Cough and a Lung Nodule. NEJM 351: 809-817 [Full Text]  
• Downey, R. J., Akhurst, T., Gonen, M., Vincent, A., Bains, M. S., Larson, S., Rusch, V. (2004). Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer Resection. JCO 22: 3255-3260 [Abstract] [Full Text]  
• Pramesh, C.S., Mistry, R. C., Deshpande, R. K., Sharma, S. (2004). Is surgery for T4 non-small-cell lung cancer worthwhile?. Ann. Thorac. Surg. 78: 753-753 [Full Text]  
• Alifano, M., Benedetti, G., Trisolini, R. (2004). Can Low-Molecular-Weight Heparin Improve the Outcome of Patients With Operable Non-Small Cell Lung Cancer?: An Urgent Call for Research. Chest 126: 601-607 [Full Text]  
• Waller, D., Peake, M.D., Stephens, R.J., Gower, N.H., Milroy, R., Parmar, M.K.B., Rudd, R.M., Spiro, S.G. (2004). Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur. J. Cardiothorac. Surg. 26: 173-182 [Abstract] [Full Text]  
• Stathopoulos, G. P., Veslemes, M., Georgatou, N., Antoniou, D., Giamboudakis, P., Katis, K., Tsavdaridis, D., Rigatos, S. K., Dimitroulis, I., Bastani, S., Loukides, S., Vergos, K., Marossis, K., Grigoratou, T., Kalatzi, E., Charalambatou, M., Paspalli, A., Michalopoulou, P., Stoka, M., Gerogianni, A. (2004). Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial. Ann Oncol 15: 1048-1055 [Abstract] [Full Text]  
• Viney, R. C., Boyer, M. J., King, M. T., Kenny, P. M., Pollicino, C. A., McLean, J. M., McCaughan, B. C., Fulham, M. J. (2004). Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer. JCO 22: 2357-2362 [Abstract] [Full Text]  
• Misthos, P., Sepsas, E., Athanassiadi, K., Kakaris, S., Skottis, I. (2004). Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 25: 502-508 [Abstract] [Full Text]  
• Spira, A., Ettinger, D. S. (2004). Multidisciplinary Management of Lung Cancer. NEJM 350: 379-392 [Full Text]  
• Blum, R. H. (2004). Adjuvant Chemotherapy for Lung Cancer -- A New Standard of Care. NEJM 350: 404-405 [Full Text]  
• Machtay, M., Lee, J. H., Stevenson, J. P., Shrager, J. B., Algazy, K. M., Treat, J., Kaiser, L. R. (2004). Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: Long-term results and associations with pathologic response. J. Thorac. Cardiovasc. Surg. 127: 108-113 [Abstract] [Full Text]  
• Barlesi, F., Doddoli, C., Chetaille, B., Torre, J.-P., Giudicelli, R., Thomas, P., Kleisbauer, J.-P., Fuentes, P. (2003). Survival and postoperative complication in daily practice after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer. ICVTS 2: 558-562 [Abstract] [Full Text]  
• Ferguson, M. K. (2003). Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis. J. Thorac. Cardiovasc. Surg. 126: 1935-1942 [Abstract] [Full Text]  
• Lim, E. H., Aggarwal, A., Agasthian, T., Wong, P.-S., Tan, C., Sim, E., Tan, L., Goh, P.-S., Wang, S.-C., Khoo, K.-L., Mukherjee, A., Khoo, S.-M., Chua, G., Nilsson, B., Lee, K.-H., Tan, P. (2003). Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers. Clin. Cancer Res. 9: 5980-5987 [Abstract] [Full Text]  
• Marra, A., Stamatis, G. (2003). Reply to the editor. J. Thorac. Cardiovasc. Surg. 126: 1665-1666 [Full Text]  
• Scagliotti, G. V., Fossati, R., Torri, V., Crino, L., Giaccone, G., Silvano, G., Martelli, M., Clerici, M., Cognetti, F., Tonato, M. (2003). Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer. JNCI J Natl Cancer Inst 95: 1453-1461 [Abstract] [Full Text]  
• Scagliotti, G. V., Turrisi, A. T. III (2003). Docetaxel-Based Combined-Modality Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer. The Oncologist 8: 361-374 [Abstract] [Full Text]  
• Altorki, N.K., Keresztes, R.S., Port, J.L., Libby, D.M., Korst, R.J., Flieder, D.B., Ferrara, C.A., Yankelevitz, D.F., Subbaramaiah, K., Pasmantier, M.W., Dannenberg, A.J. (2003). Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non-Small-Cell Lung Cancer. JCO 21: 2645-2650 [Abstract] [Full Text]  
• DeCamp, M. M., Rice, T. W., Adelstein, D. J., Chidel, M. A., Rybicki, L. A., Murthy, S. C., Blackstone, E. H. (2003). Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 126: 17-25 [Abstract] [Full Text]  
• Kimura, H., Iwai, N., Ando, S., Kakizawa, K., Yamamoto, N., Hoshino, H., Anayama, T. (2003). A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers. Ann. Thorac. Surg. 75: 1734-1739 [Abstract] [Full Text]  
• Osaki, T., Sugio, K., Hanagiri, T., Takenoyama, M., Yamashita, T., Sugaya, M., Yasuda, M., Yasumoto, K. (2003). Survival and prognostic factors of surgically resected T4 non-small cell lung cancer. Ann. Thorac. Surg. 75: 1745-1751 [Abstract] [Full Text]  
• Betticher, D. C., Hsu Schmitz, S.-F., Totsch, M., Hansen, E., Joss, C., von Briel, C., Schmid, R. A., Pless, M., Habicht, J., Roth, A. D., Spiliopoulos, A., Stahel, R., Weder, W., Stupp, R., Egli, F., Furrer, M., Honegger, H., Wernli, M., Cerny, T., Ris, H.-B. (2003). Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung Cancer: A Multicenter Phase II Trial. JCO 21: 1752-1759 [Abstract] [Full Text]  
• Wirth, L. J., Lucca, J., Ostler, P., Fidias, P., Lynch, C., Janne, P. A., Herbst, R. S., Johnson, B. E., Sugarbaker, D. J., Mathisen, D. J., Lukanich, J. M., Choi, N. C., Berman, S. M., Skarin, A. T. (2003). Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, then Surgery in Stage III Non-Small Cell Lung Cancer: A Phase I Study. Clin. Cancer Res. 9: 1698-1704 [Abstract] [Full Text]  
• Sakao, Y., Sakuragi, T., Natsuaki, M., Itoh, T. (2003). Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung. Ann. Thorac. Surg. 75: 1113-1117 [Abstract] [Full Text]  
• Cullen, M (2003). Lung cancer * 4: Chemotherapy for non-small cell lung cancer: the end of the beginning. Thorax 58: 352-356 [Abstract] [Full Text]  
• Marra, A., Hillejan, L., Zaboura, G., Fujimoto, T., Greschuchna, D., Stamatis, G. (2003). Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis. J. Thorac. Cardiovasc. Surg. 125: 543-553 [Abstract] [Full Text]  
• Danesi, R., De Braud, F., Fogli, S., De Pas, T. M., Di Paolo, A., Curigliano, G., Del Tacca, M. (2003). Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer. Pharmacol. Rev. 55: 57-103 [Abstract] [Full Text]  
• Choi, Y. S., Shim, Y. M., Kim, J., Kim, K. (2003). Mediastinoscopy in patients with clinical stage I non-small cell lung cancer. Ann. Thorac. Surg. 75: 364-366 [Abstract] [Full Text]  
• Nagai, K., Tsuchiya, R., Mori, T., Tada, H., Ichinose, Y., Koike, T., Kato, H. (2003). A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J. Thorac. Cardiovasc. Surg. 125: 254-260 [Abstract] [Full Text]  
• Yamamoto, K., Padilla Alarcon, J., Calvo Medina, V., Garcia-Zarza, A., Pastor Guillen, J., Blasco Armengod, E., Paris Romeu, F. (2003). Surgical results of stage I non-small cell lung cancer: comparison between elderly and younger patients. Eur. J. Cardiothorac. Surg. 23: 21-25 [Abstract] [Full Text]  
• Ohta, M., Sawabata, N., Maeda, H., Matsuda, H. (2003). Efficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer. J. Thorac. Cardiovasc. Surg. 125: 96-100 [Abstract] [Full Text]  
• Mattson, K. V., Abratt, R. P., ten Velde, G., Krofta, K. (2003). Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study. Ann Oncol 14: 116-122 [Abstract] [Full Text]  
• Spiro, S.G. (2003). Surgery for nonsmall cell lung cancer: can improvements be made?. Eur Respir J 21: 52S-56s [Abstract] [Full Text]  
• Toloza, E. M., Harpole, L., Detterbeck, F., McCrory, D. C. (2003). Invasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence. Chest 123 : 157S-166S [Abstract] [Full Text]  
• Choi, Y. S., Shim, Y. M., Kim, J., Kim, K. (2002). Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 22: 695-700 [Abstract] [Full Text]  
• Spiro, S. G., Porter, J. C. (2002). Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment. Am. J. Respir. Crit. Care Med. 166: 1166-1196 [Abstract] [Full Text]  
• Cyjon, A., Nili, M., Fink, G., Kramer, M. R., Fenig, E., Sandbank, J., Sulkes, A., Rakowsky, E. (2002). Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation. Ann. Thorac. Surg. 74: 342-347 [Abstract] [Full Text]  
• Stamatis, G., Djuric, D., Eberhardt, W., Pottken, C., Zaboura, G., Fechner, S., Fujimoto, T. (2002). Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur. J. Cardiothorac. Surg. 22: 292-297 [Abstract] [Full Text]  
• Osaki, T., Oyama, T., Gu, C.-D., Yamashita, T., So, T., Takenoyama, M., Sugio, K., Yasumoto, K. (2002). Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non-Small-Cell Lung Cancer. JCO 20: 2930-2936 [Abstract] [Full Text]  
• De Pas, T., Pastorino, U., Spaggiari, L., Curigliano, G., de Braud, F., Robertson, C. (2002). Preoperative Chemotherapy in Non-Small-Cell Lung Cancer: Nothing New in N2 Disease. JCO 20: 2603-2604 [Full Text]  
• Mok, T. S.K., Zee, B., Depierre, A., Westeel, V., Milleron, B., Moro-Sibilot, D., Quoix, E., Braun, D., Lebeau, B. (2002). Adequate Lymph Node Staging Is Fundamental to Comparative Study on Resectable Non-Small-Cell Lung Cancer. JCO 20: 2604-2605 [Full Text]  
• Chirikos, T. N., Hazelton, T., Tockman, M., Clark, R. (2002). Screening for Lung Cancer With CT* : A Preliminary Cost-effectiveness Analysis. Chest 121: 1507-1514 [Abstract] [Full Text]  
• Martin, J., Ginsberg, R. J., Venkatraman, E. S., Bains, M. S., Downey, R. J., Korst, R. J., Kris, M. G., Rusch, V. W. (2002). Long-Term Results of Combined-Modality Therapy in Resectable Non-Small-Cell Lung Cancer. JCO 20: 1989-1995 [Abstract] [Full Text]  
• Verschakelen, J.A., Bogaert, J., De Wever, W. (2002). Computed tomography in staging for lung cancer. Eur Respir J 19: 40S-48s [Abstract] [Full Text]